Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma

Traffic

Volumn 8, Issue 10, 2007, Pages 1415-1423

  Bachert, Collin ^a   Fimmel, Claus ^b   Linstedt, Adam D ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Biomarker; Endosome; Furin; Golgi; GP73; Hepatocellular carcinoma

Indexed keywords

ALANINE; BIOLOGICAL MARKER; FURIN; MEMBRANE PROTEIN; PROTEIN GP73; SERINE PROTEINASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CELL CULTURE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DNA CLEAVAGE; EARLY INTERVENTION; ENDOSOME; GOLGI COMPLEX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN SECRETION; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; ENDOSOMES; GOLGI APPARATUS; HELA CELLS; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PROPROTEIN CONVERTASES; RATS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548574762     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2007.00621.x     Document Type: Article

References (42)

1. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS, Dwek RA, Mattu TS, Mehta AS. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A 2005; 102: 779-784.
2. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 2005; 43: 1007-1012.
3. Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12: 1175-1181.
4. Wright L, Kreikemeier J, Fimmel C. A concise review of serum markers for hepatocellular cancer. Cancer Detect Prev 2007; 31: 35-44.
5. Marrero JA, Lok AS. Newer markers for hepatocellular carcinoma. Gastroenterology 2004; 127 (Suppl. 1): S113-S119.
6. Puri S, Bachert C, Fimmel CJ, Linstedt AD. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 2002; 3: 641-653.
7. Mallard F, Antony C, Tenza D, Salamero J, Goud B, Johannes L. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J Cell Biol 1998; 143: 973-990.
8. Mallet WG, Maxfield FR. Chimeric forms of furin and TGN38 are transported with the plasma membrane in the trans-Golgi network via distinct endosomal pathways. J Cell Biol 1999; 146: 345-359.
9. Nakayama K. Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 1997; 327: 625-635.
10. Rockwell NC, Krysan DJ, Komiyama T, Fuller RS. Precursor processing by kex2/furin proteases. Chem Rev 2002; 102: 4525-4548.
11. Khatib AM, Siegfried G, Chretien M, Metrakos P, Seidah NG. Proprotein convertases in tumor progression and malignancy: Novel targets in cancer therapy. Am J Pathol 2002; 160: 1921-1935.
12. Rovere C, Barbero P, Maoret JJ, Laburthe M, Kitabgi P. Pro-neurotensin/ neuromedin N expression and processing in human colon cancer cell lines. Biochem Biophys Res Commun 1998; 246: 155-159.
13. Cheng M, Watson PH, Paterson JA, Seidah N, Chretien M, Shiu RP. Pro-protein convertase gene expression in human breast cancer. Int J Cancer 1997; 71: 966-971.
14. Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ. 'Proprotein convertases: "master switches"in the regulation of tumor growth and progression. Mol Carcinog 2005; 44: 151-161.
15. Bassi DE, Mahloogi H, Al-Saleem L, Lopez De Cicco R, Ridge JA, Klein-Szanto AJ. Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog 2001; 31: 224-232.
16. Bassi DE, Mahloogi H, Lopez De Cicco R, Klein-Szanto A. Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol 2003; 162: 439-447.
17. Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, Koutoubi Z, Fimmel CJ. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 2000; 249: 53-65.
18. Molloy SS, Anderson ED, Jean F, Thomas G. Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis. Trends Cell Biol 1999; 9: 28-35.
19. Cameron A, Appel J, Houghten RA, Lindberg I. Polyarginines are potent furin inhibitors. J Biol Chem 2000; 275: 36741-36749.
20. Sarac MS, Cameron A, Lindberg I. The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo. Infect Immun 2002; 70: 7136-7139.
21. Marchenko GN, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI, Strongin AY. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J 2001; 356: 705-718.
22. Ohkubo S, Miyadera K, Sugimoto Y, Matsuo K, Wierzba K, Yamada Y. Identification of substrate sequences for membrane type-1 matrix metalloproteinase using bacteriophage peptide display library. Biochem Biophys Res Commun 1999; 266: 308-313.
23. Pan W, Arnone M, Kendall M, Grafstrom RH, Seitz SP, Wasserman ZR, Albright CF. Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display. J Biol Chem 2003; 278: 27820-27827.
24. Turk BE, Huang LL, Piro ET, Cantley LC. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat Biotechnol 2001; 19: 661-667.
25. Hospital V, Nishi E, Klagsbrun M, Cohen P, Seidah NG, Prat A. The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF). Biochem J 2002; 367: 229-238.
26. Hospital V, Prat A. Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation. Protein Pept Lett 2004; 11: 501-508.
27. Takahashi S, Nakagawa T, Kasai K, Banno T, Duguay SJ, Van de Ven WJ, Murakami K, Nakayama K. A second mutant allele of furin in the processing-incompetent cell line, LoVo. Evidence for involvement of the homo B domain in autocatalytic activation. J Biol Chem 1995; 270: 26565-26569.
28. Miranda L, Wolf J, Pichuantes S, Duke R, Franzusoff A. Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytes. Proc Natl Acad Sci U S A 1996; 93: 7695-7700.
29. Seidah NG, Hamelin J, Mamarbachi M, Dong W, Tardos H, Mbikay M, Chretien M, Day R. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases. Proc Natl Acad Sci U S A 1996; 93: 3388-3393.
30. Linstedt AD, Mehta A, Suhan J, Reggio H, Hauri HP. Sequence and overexpression of GPP130/GIMPc: Evidence for saturable pH-sensitive targeting of a type II early Golgi membrane protein. Mol Biol Cell 1997; 8: 1073-1087.
31. Kurokawa Y, Matoba R, Nakamori S, Takemasa I, Nagano H, Dono K, Umeshita K, Sakon M, Monden M, Kato K. PCR-array gene expression profiling of hepatocellular carcinoma. J Exp Clin Cancer Res 2004; 23: 135-141.
32. Plaimauer B, Mohr G, Wernhart W, Himmelspach M, Dorner F, Schlokat U. 'Shed'furin: Mapping of the cleavage determinants and identification of its C-terminus. Biochem J 2001; 354: 689-695.
33. Rivinoja A, Kokkonen N, Kellokumpu I, Kellokumpu S. Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen. J Cell Physiol 2006; 208: 167-174.
34. Hoshino H, Konda Y, Takeuchi T. Co-expression of the proprotein-processing endoprotease furin and its substrate transforming growth factor beta1 and the differentiation of rat hepatocytes. FEBS Lett 1997; 419: 9-12.
35. Blanchette F, Rudd P, Grondin F, Attisano L, Dubois CM. Involvement of Smads in TGFbeta1-induced furin (fur) transcription. J Cell Physiol 2001; 188: 264-273.
36. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C, Janeau JL, Bezeaud A, Delforge D, Cubizolles M, Laurendeau I, Bedossa P. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 2005; 41: 40-47.
37. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 2002; 35: 1431-1440.
38. McMahon S, Laprise MH, Dubois CM. Alternative pathway for the role of furin in tumor cell invasion process. Enhanced MMP-2 levels through bioactive TGFbeta. Exp Cell Res 2003; 291: 326-339.
39. Akhurst RJ, Derynck R. TGF-beta signaling in cancer -a double-edged sword. Trends Cell Biol 2001; 11: S44-S51.
40. Komada M, Hatsuzawa K, Shibamoto S, Ito F, Nakayama K, Kitamura N. Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin. FEBS Lett 1993; 328: 25-29.
41. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, NY; 1988.
42. Puthenveedu MA, Bachert C, Puri S, Lanni F, Linstedt AD. GM130 and GRASP65-dependent lateral cisternal fusion allows uniform Golgi-enzyme distribution. Nat Cell Biol 2006; 8: 238-248.